VENUVENUAMEX

Revenue (LTM)

$18M

+41.6% YoY

Net Income (LTM)

$-30M

-188.3% YoY

Free Cash Flow

$-69M

Revenue CAGR (5Y)

+43.5%

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 22	Dec 23	Dec 24
Revenue	9	13↑45.5%	18↑41.6%
Gross Profit	3	5↑46.2%	7↑47.6%
Operating Income	-5	-11↓133.7%	-27↓145.9%
Net Income	-7	-11↓52.0%	-30↓188.3%
EBITDA	-6	-9↓42.4%	-28↓208.4%
EPS Diluted	-0.18	-0.28↓55.6%	-0.81↓189.3%

Metric	Dec 22	Dec 23	Dec 24
Cash & Equivalents	23	20↓13.9%	38↑88.0%
Total Current Assets	24	21↓13.7%	39↑89.6%
Total Assets	53	83↑57.3%	178↑114.4%
Total Current Liabilities	3	5↑40.8%	25↑399.0%
Total Liabilities	14	21↑50.3%	48↑124.1%
Total Equity	16	31↑92.6%	96↑211.3%
Total Debt	11	15↑34.7%	27↑75.6%
Net Debt	-12	-5↑60.0%	-11↓127.3%

Metric	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-1	-5↓595.9%	4↑177.1%
Capital Expenditure	-8	-31↓283.8%	-72↓132.6%
Free Cash Flow	-9	-36↓308.6%	-69↓90.7%
Stock-Based Comp	1	2↑65.4%	12↑646.1%
Net Change in Cash	19	-3↓117.0%	18↑643.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance